Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$5.5M
2 rounds on record
Latest round
$3.5M
Series A · Apr 2020 · 6 yr ago
Team
16
US Form 5500 (plan participants) · Dec 2025 · -24% in a year
The money's age
Long since its last round
77 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2025 Team shrank to 16 was 21 · US Form 5500 (plan participants) Jul 29, 2020 Board appointment Zeteo Tech Appoints Former U.S. Assistant Secretary of Defense Andrew Weber to Board of Directors · zeteotech.com Apr 9, 2020 Raised a round Series A $3.5M Nov 13, 2017 Raised a round Venture round $2M · SEC Form D 2017 Founded
Funding rounds
RoundDateAmountInvestorsSource
Series A Apr 2020 $3.5M — zeteotech.com
Venture round Nov 2017 $2M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Zeteo Tech, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Charles CallExecutive Officer, DirectorSEC Form D
Wayne BrydenExecutive Officer, DirectorSEC Form D
Similar startupsby what they do, their industry and backers
The Medical Device Business Journal — Medical Device News & Articles | MassDevice.
Medical Device Developmentto Enhance the Quality of Life. 再生医療機器開発.
Keyron51-200 employees
Advanced medical devices for the treatment of metabolic diseases.
Qufora51-200 employees
Qufora is a medical device company that works to enable people with chronic bowel disorders to live a better life. Your life Our…
Infera2 roles
Infera helps medical device teams connect requirements, risk management, verification, and document control with AI-powered compliance…
Owlo11-50 employees
Owlo is a deep-tech company developing the next generation of non-invasive microscopy for healthcare.

Overview

Enabling Next-Generation Biodefense Solutions Zeteo Tech is a venture-backed biodefense and medical device company that has developed a revolutionary new class of fieldable biological mass spectrometers.

News

Blog 2 months ago
Our Technology
Our Technology Zeteo Tech offers research and development services associated with the use of our digitalMALDI mass spectrometers and systems. In addition to our core digitalMALDI aerosol time-to-flight mass spectrometer capabilities, our state-of-art lab
Read more
Report
Blog 2 years ago
PNAS Nexus Publishes BreathBiomics
Zeteo Tech is thrilled to announce that its Director of Biomedical Programs', Dapeng Chen, has had his groundbreaking work published in PNAS Nexus.Using human exhaled breath for disease diagnosis has long been a dream. Zeteo has made significant strides b
Read more
Report
Award 2 years ago
Zeteo Tech and Texas A&M University Awarded Phase I STTR Grant from the U.S. Department of Defense
Researchers collaborated to develop a prototype for an aerosol particle collector to integrate with microsensors for in-field threat monitoring Sykesville, MD - September 19, 2024 - Zeteo Tech, Inc., the biodefense and medical device company that has deve
Read more
Report
Award 2 years ago
Zeteo Tech Inc. Awarded $175K NOAA SBIR Phase I Grant to Develop Cutting-Edge Aerosol Detection System for Harmful Algal Blooms (HAB)
Zeteo Tech, Inc. is proud to announce that it has been awarded a $175,000 Small Business Innovation Research (SBIR) Phase I grant from the National Oceanic and Atmospheric Administration (NOAA). This funding under grant number NA24OARX021G0001-T1-01 will
Read more
Report
Award 3 years ago
Zeteo Tech Awarded $1.87M DHS Science & Technology Directorate Contract to Develop and Test the Next Generation of the digitalMALDI Real-Time Biological Threat Detection Technology
We are excited to share that the U.S. Department of Homeland Security has awarded Zeteo Tech a Phase III Small Business Innovation Research contract for $1.87M, with a potential value of up to $5.86 million. This new contract will fund the development and
Read more
Report
Award businesswire 3 years ago
Zeteo Tech Awarded $1.87M DHS Science & Technology Directorate Contract to Develop and Test the Next Generation of the digitalMALDI Real-Time Biological Threat Detection Technology
Zeteo Tech Awarded Phase III Small Business Innovation Research contract for $1.87M from the U.S. Department of Homeland Security
Read more
Report
Blog 3 years ago
Zeteo Tech Expands IP Portfolio of Mass Spectrometry Technology
SYKESVILLE, Md.-(BUSINESS WIRE)-Zeteo Tech, Inc., the biodefense and medical device company that has developed a revolutionary new class of fieldable biological mass spectrometers and innovative human breath detection technologies, announced today the iss
Read more
Report
Blog 3 years ago
BreathBiomics
BreathBiomicsTM Technology Unlocking the full potential of human breath as a non-invasive source for disease diagnosis requires technologies that are both sensitive and robust. At Zeteo Tech, we've answered this call by developing a sampling system that e
Read more
Report
Award 3 years ago
Zeteo Tech Awarded Competitive Grant From the National Institute of Allergy and Infectious Diseases
Small Business Innovation Research Program provides seed funding to fuel R&D for ZeteoTech's Innovative Approach for Detecting Disease Markers in Human Breath. Zeteo Tech, Inc. the biodefense and medical device company that has developed arevolutionary ne
Read more
Report
Show more news

People

Charles Call
Executive Officer, Director
Wayne Bryden
Executive Officer, Director
David Seldin
Director
Thomas McCreery
Director
R. Edelman
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Sykesville United States
HQ
Phone: 443.609.2003
50-200 est. staff
6935 Warfield Avenue, Sykesville, MD 21784
company site

Financials

Total raised
$5.5M
Latest round
Series A
Funding rounds
2
Funding rounds
Round Announced Amount
Series A 2020 $3.5M Details
Venture - Series Unknown 2017 $2M Details